Table 2.

ROAR Assessments and Study Activities

	Pre-Release ROAR Activities								Release Day	Post-Release ROAR Evaluation Visits
Tests/ Procedures	Prescreen		Consent & Baseline	CRM Reach In Visits			Health Services			2 Week Check In	1 Month Check In	2 Month Check In	3 Month Follow Up (& Qualitative Interview)	4 Month Check In	5 Month Check In	6 Month Follow Up
Study Visit Number	PS1	PS2	Consent & Baseline Interview	CRM1	CRM 2	CRM 3 (optional)	HS1	HS2	V0	V1	V2	V3	V4	V5	V6	V7
Approximate Weeks Post-Release	−12	−8	−6	−4	−2	−1	−4	−1	0	2	4	8	12	16	20	24
Medical Chart Review	X
Prescreen Interview (DSM-5 OUD)		X
Inclusion/Exclusion Checklist		X
Demographics (Informed Consent and Consent Quiz)			X
Locator Form			X
Medical Status			X
Baseline Overdose			X
Baseline Psychiatric Status/Mental Health Treatment			X
PHQ-9			X
Liver Function Test							X
Pregnancy Test and Birth Control Assessment								X
Naloxone Challenge Log								X
Clinical Opiate Withdrawal Scale								X
XR-NTX Injection Log								X
Injection Site Abnormality Log								X
Follow Up Locator Form										X	X	X	X		X	X
Follow-up Medical Status													X			X
Employment / Support Status													X			X
Alcohol and Drug Use													X			X
Follow-up Overdose													X			X
Family/Social Relationships													X			X
Follow-up Psychiatric Status/Mental Health Treatment													X			X
Follow-up PHQ-9													X			X
World Health Organization Quality of Life-8													X			X
Pregnancy & Birth Control													X			X
Criminal Justice													X			X
Treatment Services Review													X			X
MOUD Treatment Adherence & Satisfaction													X			X
Qualitative interview (if randomly chosen)													X
CRM Reach-In Log				X	X	X	X	X	X	X	X	X	X	X	X	X